Results 131 to 140 of about 175,762 (228)

The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells

, 2000
Single-chain urokinase-type plasminogen activator (scu-PA) is cleaved by thrombin, resulting in an inactive molecule called thrombin-cleaved two-chain urokinase-type plasminogen activator (tcu-PA/T). There is no knowledge about cell-mediated inactivation
Collen, A., Rijken, D.C., Grimbergen, J.M., Jie, A.F.H., Braat, E.A.M.   +4 more
core  

Evaluation of Serum Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels in Different Metabolic Obesity Phenotypes and Their Association with Inflammatory Cytokines: A Cross-Sectional Study. [PDF]

J Clin Med
Acet A, Ozdemir C, Solak H.
europepmc   +1 more source

Urokinase-Type Plasminogen Activator [PDF]

, 2020
openaire   +1 more source

Molecular epidemiology of the expression of urokinase plasminogen activator receptor-associated protein (uPARAP) in mesenchymal malignancies. [PDF]

Transl Oncol
Wang CC, Barkholt P, Wozniak A, Vanleeuw U, Lee CJ, De Sutter L, De Cock L, Verbeeck K, Engelholm LH, Lynch C, Mumberg D, Schöffski P.   +11 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor and perioperative complications: a systematic review. [PDF]

BMC Anesthesiol
Gungor AB, Pennathur P, Guran HS, Chu W, Roshanov PS.   +4 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor is a prognostic biomarker in decompensated cirrhosis. [PDF]

JHEP Rep
Lamatsch S, Hassan M, Kappert K, Berger H, Bai Q, Zhao Z, Walia N, De La Peña-Ramirez C, Mohr R, Demir M, Wang J, Artusa F, Sittner R, Andreola F, Veelken R, van Boemmel F, Schumacher J, Aehling N, Fischer J, Mookerjee R, Hu T, Berg T, Jalan R, Tacke F, Kumar P, Engelmann C.   +25 more
europepmc   +1 more source

Polypeptide inhibitors of urokinase type plasminogen activator

A conjugate which is capable of specific binding to and inhibition of urokinase-type plasminigen activator (UPA) comprising a polypeptide molecule and a scaffold molecule, wherein said polypeptide molecule is attached to said scaffold molecule by at ...
Winter, Greg, Angelini, Alessandro, Heinis, Christian   +2 more
core  

Differentiating borderline HER2-expressing and HER2-positive cancers from other subtypes using serum urokinase plasminogen activator. [PDF]

Br J Cancer
López Mujica MEJ, Boonkaew S, Christensen NL, Abildgaard Pedersen M, Riegels Jørgensen K, Holm Vendelbo M, Ferapontova EE.   +6 more
europepmc   +1 more source

The relationship of soluble urokinase plasminogen activator receptor levels with preterm premature rupture of membranes and predictive value in neonatal intensive care unit admission. [PDF]

Rev Assoc Med Bras (1992)
Koc BL, Tanacan A, Haliloglu E, Yilmaz HE, Ersak DT, Aktas BA, Aktas BA, Kara O, Sahin D.   +8 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Mediates the Impact of Diabetes on Adverse Outcomes in Coronary Artery Disease. [PDF]

Diabetes Care
Sakr SM, Desai S, Medina-Inojosa J, Liu C, Razavi AC, Yadalam AK, Ko YA, Ahmed T, Harris KA, Huang J, Yeboah R, Haroun N, Hartsfield JD, Owais M, Lodhi R, Eldaidamouni AA, Al Kasem M, Ali MK, Narayan KMV, Pasquel FJ, Tandon N, Mohan V, Quyyumi AA.   +22 more
europepmc   +1 more source